Commonwealth Bank of Australia’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-470
| Closed | -$59K | – | 1073 |
|
2019
Q2 | $59K | Buy |
470
+152
| +48% | +$19.1K | ﹤0.01% | 969 |
|
2019
Q1 | $41K | Hold |
318
| – | – | ﹤0.01% | 980 |
|
2018
Q4 | $28K | Buy |
318
+17
| +6% | +$1.5K | ﹤0.01% | 1000 |
|
2018
Q3 | $40K | Buy |
301
+100
| +50% | +$13.3K | ﹤0.01% | 1009 |
|
2018
Q2 | $23K | Buy |
201
+80
| +66% | +$9.15K | ﹤0.01% | 731 |
|
2018
Q1 | $12K | Sell |
121
-100
| -45% | -$9.92K | ﹤0.01% | 752 |
|
2017
Q4 | $24K | Sell |
221
-4
| -2% | -$434 | ﹤0.01% | 696 |
|
2017
Q3 | $30K | Sell |
225
-706
| -76% | -$94.1K | ﹤0.01% | 692 |
|
2017
Q2 | $112K | Sell |
931
-38
| -4% | -$4.57K | ﹤0.01% | 685 |
|
2017
Q1 | $118K | Buy |
969
+23
| +2% | +$2.8K | ﹤0.01% | 658 |
|
2016
Q4 | $116K | Buy |
946
+46
| +5% | +$5.64K | ﹤0.01% | 620 |
|
2016
Q3 | $111K | Hold |
900
| – | – | ﹤0.01% | 618 |
|
2016
Q2 | $105K | Sell |
900
-7
| -0.8% | -$817 | ﹤0.01% | 606 |
|
2016
Q1 | $126K | Buy |
907
+183
| +25% | +$25.4K | ﹤0.01% | 613 |
|
2015
Q4 | $137K | Buy |
724
+186
| +35% | +$35.2K | ﹤0.01% | 642 |
|
2015
Q3 | $84K | Buy |
538
+109
| +25% | +$17K | ﹤0.01% | 673 |
|
2015
Q2 | $77K | Buy |
429
+229
| +115% | +$41.1K | ﹤0.01% | 639 |
|
2015
Q1 | $35K | Sell |
200
-100
| -33% | -$17.5K | ﹤0.01% | 736 |
|
2014
Q4 | $56K | Sell |
300
-3,800
| -93% | -$709K | ﹤0.01% | 678 |
|
2014
Q3 | $680K | Sell |
4,100
-100
| -2% | -$16.6K | 0.01% | 549 |
|
2014
Q2 | $656K | Sell |
4,200
-12,578
| -75% | -$1.96M | 0.01% | 539 |
|
2014
Q1 | $2.55M | Buy |
16,778
+3,500
| +26% | +$533K | 0.02% | 598 |
|
2013
Q4 | $1.77M | Buy |
13,278
+1,578
| +13% | +$210K | 0.01% | 660 |
|
2013
Q3 | $1.36M | Hold |
11,700
| – | – | 0.01% | 672 |
|
2013
Q2 | $1.08M | Buy |
+11,700
| New | +$1.08M | 0.01% | 713 |
|